Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (459) Arrow Down
Filter Results: (459) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (459)
    • News  (140)
    • Research  (224)
    • Multimedia  (8)
  • Faculty Publications  (138)

Show Results For

  • All HBS Web  (459)
    • News  (140)
    • Research  (224)
    • Multimedia  (8)
  • Faculty Publications  (138)
← Page 15 of 459 Results →
  • June 2021
  • Article

From Predictions to Prescriptions: A Data-driven Response to COVID-19

By: Dimitris Bertsimas, Léonard Boussioux, Ryan Cory-Wright, Arthur Delarue, Vassilis Digalakis Jr, Alexander Jacquillat, Driss Lahlou Kitane, Galit Lukin, Michael Lingzhi Li, Luca Mingardi, Omid Nohadani, Agni Orfanoudaki, Theodore Papalexopoulos, Ivan Paskov, Jean Pauphilet, Omar Skali Lami, Bartolomeo Stellato, Hamza Tazi Bouardi, Kimberly Villalobos Carballo, Holly Wiberg and Cynthia Zeng
The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at... View Details
Keywords: COVID-19; Health Pandemics; AI and Machine Learning; Forecasting and Prediction; Analytics and Data Science
Citation
Read Now
Related
Bertsimas, Dimitris, Léonard Boussioux, Ryan Cory-Wright, Arthur Delarue, Vassilis Digalakis Jr, Alexander Jacquillat, Driss Lahlou Kitane, Galit Lukin, Michael Lingzhi Li, Luca Mingardi, Omid Nohadani, Agni Orfanoudaki, Theodore Papalexopoulos, Ivan Paskov, Jean Pauphilet, Omar Skali Lami, Bartolomeo Stellato, Hamza Tazi Bouardi, Kimberly Villalobos Carballo, Holly Wiberg, and Cynthia Zeng. "From Predictions to Prescriptions: A Data-driven Response to COVID-19." Health Care Management Science 24, no. 2 (June 2021): 253–272.
  • April 2011
  • Supplement

Brazil: Leading the BRICs? (PPT)

By: Arthur A. Daemmrich
Keywords: Brazil
Citation
Purchase
Related
Daemmrich, Arthur A. "Brazil: Leading the BRICs? (PPT)." Harvard Business School PowerPoint Supplement 711-106, April 2011.
  • 1995
  • Chapter

Pharmaceutical Companies and Health Care Reform

By: Arthur A. Daemmrich
Keywords: Health Care and Treatment; Governing Rules, Regulations, and Reforms; Government and Politics; Policy; Business and Government Relations; Pharmaceutical Industry
Citation
Related
Daemmrich, Arthur A. "Pharmaceutical Companies and Health Care Reform." In Global Issues Guidebook, edited by Laura Baraff and Nicola Short, 403–407. Student Pugwash USA, 1995.
  • 1999
  • Chapter

Biotechnology, Competitiveness and the Regulatory State

By: Arthur A. Daemmrich
Keywords: Technological Innovation; Innovation Strategy; Competitive Advantage; Governing Rules, Regulations, and Reforms; Government and Politics; Policy; Business and Government Relations; Biotechnology Industry
Citation
Related
Daemmrich, Arthur A. "Biotechnology, Competitiveness and the Regulatory State." In An Assessment of the German Biotechnology Sector in Comparative Perspective, edited by Stephen J. Silvia, 33–48. American Institute for Contemporary German Studies, 1999.
  • 2004
  • Chapter

L'industria farmaceutica

By: Arthur A. Daemmrich
Keywords: Pharmaceutical Industry
Citation
Related
Daemmrich, Arthur A. "L'industria farmaceutica." In Storia della scienza, v. 8, 869–874. Istituto della Enciclopedia Italiana, 2004.
  • September 2004
  • Article

Rethinking Mergers and Acquisitions: How to Involve R&D in Company Growth

By: Arthur A. Daemmrich
Keywords: Mergers and Acquisitions; Research and Development; Growth and Development; Business Ventures
Citation
Related
Daemmrich, Arthur A. "Rethinking Mergers and Acquisitions: How to Involve R&D in Company Growth." Chemistry Business (September 2004).
  • 13 Mar 2007
  • First Look

First Look: March 13, 2007

site for paper: http://www.bepress.com/cas/vol1/iss3/art3/ Identity Negotiation Processes Amidst Diversity: Understanding the Influence of Social Identity and Status Differences Authors:Jeffrey T. Polzer and Heather M. Caruso Publication:In Diversity at Work, edited... View Details
Keywords: Martha Lagace
  • October 2012
  • Teaching Note

GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships

By: Arthur A. Daemmrich
Citation
Purchase
Related
Daemmrich, Arthur A. "GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships." Harvard Business School Teaching Note 713-044, October 2012.
  • December 2010
  • Supplement

Denmark: Globalization and the Welfare State (PPT)

By: Arthur A. Daemmrich
Citation
Purchase
Related
Daemmrich, Arthur A. "Denmark: Globalization and the Welfare State (PPT)." Harvard Business School PowerPoint Supplement 711-057, December 2010.
  • December 2010 (Revised April 2012)
  • Background Note

Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round

By: Arthur A. Daemmrich
This note analyzes disputes over intellectual property enforcement and agricultural trade barriers at the center of the Doha Round of World Trade Organization (WTO) negotiations. Fundamental principles of intellectual property rights and agricultural subsidies are... View Details
Keywords: Agribusiness; Trade; Globalization; Governance; International Relations; Intellectual Property; Agreements and Arrangements; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Daemmrich, Arthur A. "Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round." Harvard Business School Background Note 711-043, December 2010. (Revised April 2012.)
  • January 2009 (Revised July 2009)
  • Case

Targanta Therapeutics: Hitting a Moving Target

By: Arthur A. Daemmrich
This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details
Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target." Harvard Business School Case 709-002, January 2009. (Revised July 2009.)
  • 2004
  • Book

R&D Meets M&A: Proceedings of the 2003 Conference on Innovation and Creativity in Chemical R&D

By: Arthur A. Daemmrich
Keywords: Research and Development; Mergers and Acquisitions; Conferences; Innovation and Invention; Creativity; Science
Citation
Read Now
Related
Daemmrich, Arthur A., ed. R&D Meets M&A: Proceedings of the 2003 Conference on Innovation and Creativity in Chemical R&D. Chemical Heritage Press, 2004.
  • January 2000
  • Article

The Tragedy of the Commoners: Biotechnology and its Publics

By: Arthur A. Daemmrich
Keywords: Biotechnology Industry
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "The Tragedy of the Commoners: Biotechnology and its Publics." Nature Biotechnology 18, no. 1 (January 2000): 2–4.
  • December 2000
  • Article

Risk versus Risk: Tragic Choices in Drug Regulation in the United States and Germany

By: Arthur A. Daemmrich
Keywords: Risk and Uncertainty; Decision Choices and Conditions; Health; United States; Germany
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "Risk versus Risk: Tragic Choices in Drug Regulation in the United States and Germany." Science as Culture 9, no. 4 (December 2000): 505–534.
  • fall 2002
  • Article

Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial

By: Arthur A. Daemmrich
Keywords: Science; Health; Courts and Trials; Pharmaceutical Industry; Germany
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial." Chemical Heritage, no. 20 (fall 2002): 12–13, 28–33.
  • Article

Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate

By: Arthur A. Daemmrich
Keywords: Cost; Health; Governing Rules, Regulations, and Reforms; Communication
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate." Pharmacy in History 45, no. 1 (2003): 3–17.
  • 07 Aug 2012
  • First Look

First Look: August 7

case:http://hbr.org/search/812158-PDF-ENG GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships Arthur A. Daemmrich and Ian McKown CornellHarvard Business School Case 712-049 Three years into a... View Details
Keywords: Sean Silverthorne
  • December 2020 (Revised December 2022)
  • Case

The Dance of Dharma: On the Difficulty of Being Good

By: Arthur I. Segel and Tyler M. Richard
When deciding how to be good and act well, we often seek outside help. Many of our oldest and most frequently consulted sources of ethical guidance are our religious traditions. Just as one might consult a thoughtful friend, countless people seek direction from their... View Details
Keywords: Hinduism; Ethics; Religion; Values and Beliefs; Decision Making
Citation
Educators
Purchase
Related
Segel, Arthur I., and Tyler M. Richard. "The Dance of Dharma: On the Difficulty of Being Good." Harvard Business School Case 821-058, December 2020. (Revised December 2022.)
  • June 2011 (Revised October 2012)
  • Case

Patagonia Sur: For-Profit Land Conservation in Chile

By: Arthur I Segel, Nicolas Ibanez and Jay Verjee
Warren Adams founded Patagonia Sur in 2007 as one of the world's first for-profit land conservation businesses. His goal was to purchase over 100,000 acres of land in southern Chile and to run a variety of sustainable businesses to generate annual returns for... View Details
Keywords: Business Model; Environmental Sustainability; Profit; Investment; For-Profit Firms; Entrepreneurship; Investment Return; Revenue; Risk and Uncertainty; Capital; SWOT Analysis; Real Estate Industry; Chile
Citation
Educators
Purchase
Related
Segel, Arthur I., Nicolas Ibanez, and Jay Verjee. "Patagonia Sur: For-Profit Land Conservation in Chile." Harvard Business School Case 211-103, June 2011. (Revised October 2012.)
  • 13 Jan 2009
  • First Look

First Look: January 13, 2009

nonprofits and corporations can create value for society more effectively by applying strategy principles to philanthropy. Part V explores the link between strategy and leadership. Risk Frameworks and Biomonitoring: Distributed Regulation... View Details
Keywords: Martha Lagace
  • ←
  • 15
  • 16
  • …
  • 22
  • 23
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.